|Publication number||US5301677 A|
|Application number||US 07/833,843|
|Publication date||Apr 12, 1994|
|Filing date||Feb 6, 1992|
|Priority date||Feb 6, 1992|
|Also published as||CA2067583A1, CA2067583C, DE69231554D1, DE69231554T2, EP0554605A1, EP0554605B1|
|Publication number||07833843, 833843, US 5301677 A, US 5301677A, US-A-5301677, US5301677 A, US5301677A|
|Original Assignee||Cardiac Pacemakers, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (6), Referenced by (234), Classifications (17), Legal Events (7)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The present invention relates to a detector for analyzing the condition of the heart and is used in conjunction with a device capable of electrically stimulating a heart experiencing ventricular fibrillation, ventricular tachycardia, supraventricular tachycardia, or other arrhythmias. Specifically, the present invention relates to a detector capable of discriminating ventricular fibrillation (VF), polymorphoric ventricular tachycardia (PVT) from other arrhythmias of the heart and discriminating ventricular tachycardia (VT) from tachycardia of supraventricular origin. The present invention also relates to a unique delta modulator that operates on the ECG signal.
It is an object of the present invention to identify an arrhythmic heart condition by analyzing the waveform (morphology) of an electrocardiogram (ECG) signal obtained from the heart.
It is another object of the present invention to analyze a digital representation of the ECG signal and apply a waveform analysis on that digital signal.
It is a further object of the present invention to utilize a delta modulated representation of the ECG signal and further identify isoelectric segments of the ECG signal based upon the delta modulated representation thereof.
It is another object of the present invention to detect fibrillation and also detect ventricular tachycardia by comparing the isoelectric line segments against two thresholds.
It is an additional object of the present invention to establish a rate dependent tachycardia threshold by monitoring the rate and morphology of the heart both in normal condition and in tachyarrhythmia.
It is another object of the present invention to utilize a unique delta modulator that includes a digital-to-analog converter and an up/down counter which digitally integrates an input signal, and which further incorporates an over-limit feature in order to accommodate an input signal which exceeds the dynamic range limits of the digital-to-analog converter.
It is an additional object of the present invention to provide a delta modulator that is completely drift free and which employs a substantially error-free integrator.
It is a further object of this invention to provide an arrhythmia detection system for measuring slew rate of an ECG signal, and including software to decide whether the ECG signal is typical of ventricular fibrillation, ventricular tachycardia, or other arrhythmias.
Another object of the present invention is to provide a toggled output for the delta modulator when the dynamic range limit of the digital-to-analog converter is exceeded in order to produce a signal which can be readily recognized.
The arrhythmia detector includes a delta modulator which digitizes the ECG signal and produces a representative serial digital signal. The serial digital signal is loaded as an 8-bit digital word into an 8-bit register, and a microprocessor counts the number of zeros in the 8-bit digital word in order to classify the signal as having no slope, positive slope, or negative slope. The definitions are established so that if more than four zeros occur, the slope is positive; if less than four zeros occur, the slope is negative; and if exactly four zeros occur, there is no slope. The microprocessor utilizes a finite state machine to determine the number of times an isoelectric line segment is present in the ECG signal based upon the series of positive (+) slope, negative (-) slope, or no slope signals. Basically, the finite state machine determines, based upon the previous state and based upon the current positive/negative or no slope signals, what the next state will be. During certain transitions between states, a line-count increment is assigned to the transition. By accumulating the line-count over a two-second period, and comparing it with two thresholds, determinations can be made on whether the ECG signal is indicative of a ventricular fibrillation, a ventricular tachycardia or supraventricular tachycardia.
This turning point morphology analysis technique is not expected to be used alone but, rather, used in conjunction with a detected heart rate signal to determine the presence of fibrillation and/or ventricular tachycardia. One line-count threshold is designed to discriminate between ventricular fibrillation and monomorphic VT and typically used between the rate zone of 150 bpm to 200 bpm. If the line-count accumulated within the two-second period is less than or equal to the first threshold then the period is considered as a condition called Fibrillation Met (Fib-Met). It takes two out of three two-second periods of the Fib-Met condition to generate a fibrillation detected condition for invoking defibrillation therapy. The second threshold is targeted at distinguishing between ventricular tachycardia and supraventricular tachycardia and it is typically applied in the rate zone 110 bpm to 150 bpm. The threshold can be decided on a rate dependent fashion by measuring the line-count and average rate in two-second periods with the ECG signal indicating normal sinus rhythm.
Using a first order approximation, a regression relation (line-count) LC=b-a*rate can be assumed for tachycardia from a supraventricular tachycardia origin, and the regression coefficients a and b obtained from the measured data pairs. With the suspected high rate in the rate zone 110 bpm and 150 bpm, and the measured coefficients a and b, a threshold LC(TH) for the line-count can be generated. When the line-count is less than the threshold, the rhythm is declared to be ventricular tachycardia and anti-tachy therapy can be invoked. Otherwise, the rhythm is judged to be from supraventricular origin, and no anti-tachy therapy will be invoked.
The delta modulator of the present invention includes a comparator that receives the ECG signal at one input and a tracking signal at the other input. A digital-to-analog converter (herein a D/A converter) generates the tracking signal for the comparator. An up/down counter supplies the digital signal to the D/A converter. The up/down counter has an up/down control input that is coupled to the output of the comparator. The up/down counter counts clock signals applied to its clock input. Therefore, when the ECG signal level is above the tracking signal level, that is, the analog version of the count in the counter, the comparator's output goes high, and the counter begins counting up. When the ECG signal level is lower than the tracking signal level, the comparator's output goes low, and the counter begins to count down. Therefore, the combination of the D/A converter and the up/down counter digitally integrate the ECG signal. The output of the comparator is a delta modulated signal.
The delta modulator of the present invention may also include an over-limit control that toggles the output of the comparator when the counter reaches its maximum or minimum count value. The counter has a Carry signal (for excessive counts) and a Not Borrow signal (for less-than-zero counts). These two signals are fed into a logic circuit that toggles the output based thereupon at the clock pulse rate.
The above and other objects and advantages of the present invention will become more readily apparent in the following description taken in conjunction with the accompanying drawings.
FIGS. 1A-1D illustrate ECG waveforms from normal sinus rhythm, supraventricular tachycardia, ventricular tachycardia and ventricular fibrillation.
FIG. 2 is a data flow diagram for the arrhythmia detector in accordance with the principles of the present invention.
FIG. 3 is a flowchart for the arrhythmia detector in accordance with the principles of the present invention.
FIG. 4 is a flowchart of the upper bit counter routine.
FIG. 5 is a condensed version of the state diagram for the present invention.
FIG. 6 is a tabular representation of the finite state machine or state diagram.
FIG. 7 is a graphical representation of the finite state machine.
FIG. 8 illustrates a thresholding waveform incorporated into the finite state machine illustrated by FIGS. 6 and 7.
FIG. 9 illustrates an ordinary ECG as it is analyzed by the finite state machine illustrated by FIGS. 6 and 7.
FIG. 10 is a flowchart illustrating the rate dependent thresholds for discriminating between supraventricular tachycardia and ventricular tachycardia.
FIG. 11 is a block diagram of the delta modulator in accordance with the further principles of the present invention.
FIG. 12 is an electrical schematic of the delta modulator in accordance with the principles of the present invention.
The present invention relates to an arrhythmia detector that can be used in an implantable cardioverter or an external automatic defibrillator or cardioverter. Particularly, the detector comprises a ventricular fibrillation and ventricular tachyarrhythmia detection algorithm that analyzes the shape of the ECG waveform or morphology of the cardiac signal obtained from the heart. The ECG signal can be obtained from intracardiac leads, surface leads or from an external sensory device coupled to an external automatic defibrillator.
The present invention also relates to a unique delta modulator structure that utilizes an up/down counter and a digital-to-analog converter.
As for the arrhythmia detector, the principle of fibrillation detection is based on the premise that the fibrillation waveform, as obtained from both surface leads on intracardiac leads (e.g., a widely placed spring to a patch or patch to patch), is somewhat sinusoidal in nature. The frequency of the quasi-sinusoidal wave is typically in the range of 2 to 9 Hz. Compared with ventricular tachycardia, supraventricular tachycardia and normal sinus rhythm waveforms, a sinusoidal ventricular fibrillation waveform has fewer isoelectric segments. Therefore, a calculation of the amount of time the overall ECG waveform is an isoelectric line is an indication of ventricular fibrillation.
FIGS. 1A-1D show a normal sinus rhythm (NSR) ECG waveform wherein the heart rate is 75 bpm (FIG. 1A), a supraventricular tachycardia (FIG. 1B) and ventricular tachycardia (FIG. 1C) both with rate of 150 bpm. A VF waveform (shown in FIG. 1D) is comprised almost entirely of sloped line segments. As shown, a normal ECG is comprised of primarily an isoelectric line except for the QRS complex. The threshold between supraventricular tachycardia and ventricular tachycardia can be decided based on a model that the line-count from NSR and supraventricular tachycardia can be related by (line-count) LC=b-a*rate, wherein line-count from ventricular tachycardia is less than the supraventricular tachycardia with equal rate. Therefore, by measuring the line-count from waveform of NSR in various rates, the regression coefficients a, b can be decided, and the threshold between supraventricular tachycardia and ventricular tachycardia can be projected from the coefficients and the measured rate from the arrhythmia in question. If the line-count is less than the threshold, the rhythm in question is classified as ventricular tachycardia. Otherwise, it is classified as tachycardia with supraventricular origin.
In one embodiment of the present invention, the ECG signal is fed to a delta modulator (described later with respect to FIGS. 11 and 12), and the delta modulator produces a serial digital output. This serial data is loaded into an 8-bit register, and the contents of the register are analyzed by a microprocessor-based control system. The microprocessor-based control system in one embodiment includes a microprocessor, a random access memory for storing variables and other items of information, and a read-only memory for storing software programs and routines which are called up by the microprocessor to operate on the various inputs supplied thereto.
Generally, the microprocessor samples the 8-bit register holding the delta modulated ECG signal at 1 KHz sampling rate. The step size of the delta modulator is 1/16 from the base line to maximum amplitude of the ECG signal or 32 steps peak-to-peak of the ECG signal. This is a 5-bit resolution for the delta modulator. Every eight milliseconds (7.8125 msec to be precise), the microprocessor counts the number of zeros in the 8-bit data word in the register in order to determine whether the slope of the delta modulated signal is up (positive), zero (no change), or down (negative). If the number of zeros is greater than four, the slope is up (+1); if the number of zeros is equal to four, there is "no slope" (0); if the number of zeros is less than four, the slope is down (-1).
Thereafter, the contextual or waveform relationship of these clusters (the 8-bit delta modulated data word) is analyzed using a finite state machine algorithm. The finite state computational model separates the clusters into flat line segments and sloped line segments, based upon the threshold of 16/125 step/ms. This corresponds to the situation in which, if the slew rate is greater than or equal to a linear monotonic rate of change from the isoelectrical line to the maximum amplitude in 125 msec, then the segments in question are defined as slope. Otherwise the segments in question are defined as a flat line. The turning points of the sloped segments can be followed by the finite state algorithm, and line-counts increments are assigned to certain state transitions, as defined by the finite state machine algorithm. The line-counts, indicative of the number of isoelectric line segments in the ECG waveform, are added up over the 2 second period, and a determination is made whether the amount of time the ECG signal is an isoelectric line is less than a predetermined threshold. If the time in isoelectric line is less than the VT/VF threshold, this two-second segment is considered Fib-Met. It takes two out of three two-second segments satisfying this condition to invoke a fibrillation detected signal.
FIG. 2 shows a data flow diagram of the present invention. DMT-FD is a label for the delta modulated turning point morphology routine. Block 50 represents analysis of the upper-bit-counter and is called every 8 msecs. The input into block 50 is the delta modulated ECG signal. An upper bit counter is utilized to determine the number of zeros in the 8-bit delta modulated signal (stored as an eight bit data word called delta-mod-ECG) and hence positive/negative or no slope of the signal. The output is the up-count.
Block 52 represents the slope tracker which receives the up-count and accumulates the line segments. The output of block 52 is a line-count and a state variable of the finite state machine called "dstate". Block 54 is the fibrillation detection thresholder which receives the line-count and the fibrillation segment flag (fib-seg-flag). Block 54 is called every two seconds and outputs a fibrillation detection flag (fib-det-flag) and a fibrillation segment flag (fib-seg-flag) that is indicative of the previous two thresholding tests. The fib-seg-flag is two bits wherein each bit represents a prior frame's threshold result.
FIG. 3 illustrates, in greater detail, the flowchart for the delta modulated turning point morphology routine (DTM-FD). Before this routine is called, various items are initialized to zero, for example, the ECG-INDEX, line-count, and dstate are all set to zero, and the fib-det-flag and fib-seg-flags are cleared. In step 60, the bits of the register DMT-MOD are examined to determine the number of zeros in this eight bit register. In step 62, a finite state machine is invoked to compare the status of the current segment with previous segments. Finally, in steps 64-80, certain thresholds are applied to output generated by the finite state machine of step 62 to determine the type of cardiac rhythm occurring.
FIG. 4 shows the detailed flowchart for upper bit counter routine 60. In step 100, the bit-count is set to zero, and the up-count is set to zero. Decision block 101 determines whether the bit-count is less than eight; and, if it is not less than eight, the routine is exited until at next examination bit-count is less than eight. If the bit-count is less than eight, decision block 103 determines whether bit 7 is equal to zero. The 8-bit data word (delta-mod-ECG) is loaded into a hardware shift register (DMT-MOD), and it is that register that is being read. The 8-bit word has bits 1, 1, 2, 3, 4, 5, 6, and 7. Steps 103 and 105 determine how many of the bits in the 8-bit register are equal to zero, and the value of up-count is equal to the number of zeros. Each time a test is made on a bit, the bit-count value is incremented in step 107, and the shift register DMT-MOD is shifted one place to the left. When all the bits have been read from the register, the routine is exited. Although up-count can have a value anywhere from 0 to 8 (0 if no zeros have been found or 8 if eight zeros have been found), for purposes of understanding the invention, if up-count is greater than four, a positive slope is identified; if up-count is equal to four, zero slope is noted; and, if up-count is less than four, a negative slope is recognized for this eight msec data as a whole.
Returning back to FIG. 3, the up-count value is supplied to the finite state slope/line tracker subroutine in step 62. Step 62 is a finite state machine algorithm which separates series of slope signals, each slope representative of an 8 msec cluster of delta modulated signals, into line segments and slope segments and assigns line-count increments to certain turning points or transitions.
A simplified finite state machine algorithm is shown in FIG. 5. The 0 state (dstate=0) defines an isoelectric line segment. Dstate is initialized to 0. If no slope is detected at the first 8 msec interval, the algorithm provides that the state remains at 0. If +1 or positive slopes are detected, the algorithm provides that state 2 is entered. If from state 0 negative slopes (-1) are detected, the state changes from 0 to 7. If from state 7 positive slopes are noted, the state changes to 2, etc., according to the finite state algorithm. Line count increments can be assigned to particular transitions between states.
FIGS. 6 and 7 represent the detailed finite state machine algorithm in accordance with the preferred embodiment of the present invention. FIG. 6 is a tabular representation of the finite state algorithm which comprises a look-up table for the destination states and the possible line-count increments accompanying state transitions to dstate 0, whereas FIG. 7 is a state diagram graphical representation of the same algorithm. In these figures, 11 states numbered 0 to 10 are represented. For certain state transitions, for example, from state 5 or state 6 in the presence of a positive input slope (1) a state transition to state 0 will occur and the line-count is incremented by 2. From state 1 or 10, a negative input slope (-1) will cause a state transition to 0 with a line-count increment of 2. Therefore, by accumulating the line-counts and maintaining a record of the source state (dstate), certain transitions to dstate 0 which are indicative of the isoelectric line segments are assigned line-count increments. It should be noted that a significant transition occurs even when the dstate does not change numerically. For example, the state transition from dstate 0 to dstate 0 in the presence of zero slope is assigned a line-count increment of 1.
By analyzing the morphology of waveshape of the ECG signal, a determination can be made as to what weight or what incremental value should be assigned to the line-count for a particular state transition.
States 0, 2, and 7 have special meanings and, as such, are termed primary states. State 0 is the primary state for line segments that have no slope. State 2 is the primary state for upward sloping segments. State 7 is the primary state for downward sloping segments.
The transition from state 0 (the ECG in isoelectric line) to state 2, requires at least two upward transitions. This corresponds to an average slope of at least 4 steps in 16 msec segment from a flat line segment. States 1 and 3, between states 0 and 2, and the transition rules that attach to them, are designed to establish a thresholding waveform. A direct state transition for state 0 to 1 to 2 in two data samples corresponds to a slope of at least 4 steps in 16 msec or from isoelectric line to maximum amplitude in 64 msec. Therefore, if slope criteria is shallower than that, some intermediate states are needed. States 1 and 3 between 0 and 2, (similarly states 6 and 8 between 0 and 7) and the transition rules that attached to them are designed to establish a threshold such that ECG segments with slew rate greater than or equal to a linear monotonic rate of change from baseline to maximum amplitude in 125 msec will be classified as slope segments; otherwise they will be classified as flat line segments. This is accomplished by distinguishing line segments with a pattern 101010101 or -10-10-1 as slope and any segments with shallower slew rate will be classified as line segments. This thresholding waveform is a 2 HZ sawtooth waveform as illustrated in FIG. 8. When a transition back to state 0 occurs (including 0 to 0 transition) line-count will be incremented by 1, 2 or 3.
Referring to FIG. 9, the analysis of an ordinary ECG is illustrated. The QRS complex is seen as having slopes steeper than that of the threshold waveform illustrated in FIG. 8. Specifically, the QRS complex has a corresponding dstate sequence of 1, 2, 5, 7. The thresholding waveform assists in discriminating slope segments from flat line segments by affecting the value of line-count in dstate transitions.
Returning to the flowchart shown in FIG. 3, a line-count is generated from the finite state machine in step 62. In step 64, the ECG-INDEX is incremented by 1. In step 66, a determination is made whether ECG-INDEX is equal to 256. When the ECG-INDEX is equal to 256, two seconds have passed, and the first threshold decision is made in step 68. In step 68, a determination is made whether the line-count is less than the VF-threshold which indicates the percentage of time the ECG is in flat line segments within this 2 seconds. From empirical studies of about 90 ECG recordings from internal leads, the threshold is set to be between 35 to 40%. It is expected to be a programmable parameter adjustable to individual patients.
If decision step 68 determines that the number of accumulated line-counts exceeds the threshold during the two-second period, the NO branch is taken to decision step, which determines which step is taken dependent upon the 2-bit value of the flag. Each bit of the flag represents a previous state of the flag. 00 represents that the flag was not activated during each of the prior two-second periods. 01 indicates that the flag was set in the last two-second period but not in the prior two-second period. 10 indicates that the flag was set in the earlier two-second period, but not in the immediately preceding two-second cycle. Steps 72 and 74 which set the fib-seg-flag to 10 if the flag was previously 01 and to 00 if the flag was previously 10 will be executed if the current segment does not exceed the VF-threshold. This subroutine in combination with the YES branch steps from step 68 is basically a voting scheme which determines in two out of the last three 2 second segments whether a fibrillation or an arrhythmia has been detected.
If YES branch is taken from decision block 68, a decision is made in step 76 whether the fib-seg-flag is 00. If YES, step 78 sets the fib-seg-flag to 01, and the routine is exited. If the decision from step 76 is such that the fib-seg-flag is not 00, then in step 80 both the most significant and least significant bits of the fib-det-flag are set which indicates that fibrillation or arrhythmia has been detected and declared, and that the most recent 2 second segment is FIB-MET. In step 80, it does not matter whether the arrhythmia was detected in the immediately preceding two-second interval (fib-seg-flag=01) or whether the arrhythmia was detected in the earlier two-second interval (fib-seg-flag=10), since the YES from step 68 indicates that two out of the three segments are FIB-MET in either case (11 or 01). At that point, the routine is exited.
Alternatively, for surface ECG's sampled at 256 samples/second, delta modulation can be performed on 4 msec data from two samples points. Contextual relations of the cluster of two points can also be followed using a similar finite state scheme.
For ventricular tachycardia detection, in contrast to ventricular fibrillation detection, there is no particular reason to fix the slope threshold for ventricular tachycardia detection to 16 steps from baseline to maximum amplitude within 125 msec. However, for simplification, it is reasonable not to change the slope thresholding for ventricular tachycardia detection but rather to change the percentage in isoelectric line threshold. For normal sinus rhythm, isoelectric line/percentage is approximately 85 percent during one cardiac cycle; for ventricular arrhythmias, the percentage is approximately 55 percent; and for supraventricular tachycardia (SVT), the percentage is around 65 to 75 percent. The main problem of poor specificity for ventricular tachycardia detection based on rate criteria alone is due to the overlap in rate of VT with that of sinus tachycardia or supraventricular tachycardia. Therefore, another thresholding technique is utilized in a preferred embodiment of the present invention.
This further technique is based on the assumption that the morphology of individual QRS complexes or "the effective width" of supraventricular tachycardia versus normal sinus rhythm will be similar for most individual patients. Therefore, the line-count derived from tachycardia with a supraventricular origin can be related to line-counts (LC) and rates in normal sinus rhythm as a linear formula LC=b-a*rate. However, the QRS complex of the ventricular tachycardia will have a different morphology, typically wider. Therefore, by collecting baseline morphology information periodically during normal sinus rhythm, and measuring the rate at the same time, a ventricular tachycardia versus supraventricular tachycardia threshold is generated on a rate dependent basis.
FIG. 10 shows a flowchart for obtaining a rate dependent threshold used to discriminate between ventricular tachycardia and supraventricular tachycardia. In step 210, during normal sinus rhythm, (rate<prl, primary rate limit parameter programmable by the physician) every hour, 20 seconds of delta modulated data is taken. For each 2 second segment, both line-counts and average rate data are measured. In step 212, the data taken so far is fit into a regression equation LC=b-a*(rate/30), where b is the line-count of the flat line, which can be initialized to 256, and a is the line-count of a very high rate, which can be initialized to 22. For each hour, a new set of 10 pairs of LC verses rate data become available, updating the set of a and b coefficients. For any arrhythmia in the rate zone where VT verses SVT is in question, after 2 seconds of delta modulated ECG data has been taken, the average rate of the latest 4 R--R intervals can also be measured. In step 214, if the rate is less than the prl, then the line-count and average rate are used to update the regression coefficients a and b in step 216. If the rate is above prl, then a threshold can be generated according to the formula LC(TH)=b-a*(rate/30), as indicated in step 218. In step 220, if the current measured LC is less than the threshold, then the arrhythmia is declared to be VT. Otherwise, it will be declared as SVT and the line-count and rate data can be used to update the regression constant a and b for future use, as shown in step 222.
FIG. 11 is a block diagram of the delta modulator in accordance with the principles of the present invention. Delta modulated data is basically the error information between an incoming waveform (herein the ECG waveform at input 1 or input 2) and a tracking waveform signal which approximates the input. Delta modulated data can be thought of as instructions for reconstructing the input by stepping up or stepping down depending on the difference between the input signal and the tracking signal. In FIG. 11, input 1 and input 2 represent two channels which are supplied to an input multiplexer which selects which input channel will be digitized. One channel may be for a bipolar lead and the other may be for a patch. Only one of the two signals can be processed at any one time. This is accomplished by the channel select switch SW and in accordance with the channel select command signal applied thereto. The selected signal is applied to a comparator 302 which determines whether the input is greater or less than the inverse of the internal tracking signal. The tracking signal is generated by numerically integrating the binary state of the comparator 302. This is accomplished by feeding back the output of the comparator 302 to the up/down control of an up/down counter 304. The up/down counter 304 is incremented or decremented per the clock signal applied to its clock input, and the digital count from the counter 304 is applied to a digital-to-analog converter 306 which in turn generates the tracking signal for the comparator.
The data analyzed by the turning point morphology technique of the present invention must be normalized for the technique to function properly. To this end, the signal on the input 1 or 2 is modified by an automatic gain control (AGC) configuration such that normalized data will be generated after a few time constants.
An important feature of this delta modulator is that the integrator is formed by an up/down counter and D/A converter. Therefore, the integrator is completely drift free and, therefore, essentially a perfect integrator. Since drift is a problem with delta modulators, this simplifies the recovering of the waveform later because drift errors will not accumulate in the delta modulated data. FIG. 12 shows a circuit schematic for the integrated circuit implementation of the delta modulator. Table I that follows shows and describes the various inputs and signals applied to the integrated circuit:
TABLE I______________________________________VDA positive voltage railCLK clockIBIAS current source (e.g., 50 na.)IN1 ECG input 1IN2 ECG input 2EGM-SEL input or channel select control lineVDD mid-level voltageVSA negative voltage rail______________________________________
Transistors P1, P2, P3, P4, P5, P6, N1, and N2 provide current mirror rails (positive rails P1-P6 and negative rails N1-N2) to provide bias current for both comparators A1 and A2. Rather than having an analog switch before the comparator, two comparators are used for each input signal (IN1 and IN2); and a multiplexer 308, controlled by select signal EGM-SEL, selects one of the outputs of comparators A1 and A2. The current mirror rails provide bias currents for the comparators, the D/A converter 306 and the synthetic resistor circuit R that is defined by transistors N3 and N4 within the dashed box. The synthetic resistor circuit R and bipolar transistor T1 provide a loan for the current output of the D/A converter 306 at points 200 and 201 such that the result is a voltage numerically proportional to the binary word presented to the D/A converter 306 by the up/down counter 304. The voltage can vary at points 200 and 201 by ±170 mV around a point of 0.5 volts between VDD. This resistor/transistor network has a Thevenin equivalent voltage designed to be equal to the no signal DC value of the input signals (IN1 and IN2) or resting voltage of the sense amplifiers IN1 and IN2. This voltage is present when the up/down counter is reading a count of 32, which is at mid-scale of the counter. The comparators are connected to VDA for a positive voltage supply, to VSA as a negative voltage supply, and to P5 and P6 respectively for bias.
Another feature of the delta modulator is the overload behavior of the entire system. If the input ECG signal exceeds the dynamic range limit of the D/A converter, the modulator reverts to a toggled output data signal which is the equivalent of straight line clipping. With any other behavior, the recovered waveform could be severely distorted following overload. This over-limit protection is accomplished using the limit reversal gating circuit 310 comprised of OR gate G5 and AND gate G6. The Carry output from the up/down counter 304 is applied to one input of OR gate G5 whereas the complement of the Borrow signal is applied to AND gate G6.
If the input signal IN1 was very high (assuming IN is selected EGM-SEL), the output of D/A converter would have to be very low since the tracking signal follows the input signal. When the counter reaches its minimum count level, i.e., attempting to go below a zero count, the Not Borrow line would, therefore, go low. When the output of the AND gate goes low, since the Not up/down control is coupled to the output of the reversal circuitry, the counter counts up one at the next clock pulse. The Not Borrow line would go high because the counter counts up one. Since the output of the comparator would remain the same, the output of AND gate G6 then goes from low to high. The counter then counts down to its minimum value again. At the next clock pulse, the Not Borrow line goes low, indicating the minimum value and the cycle repeats. Therefore, the modulated output signal is toggled at the clock rate. A similar analysis applies for the over-limit control that is operated with the carry line and OR gate G6.
Flip-flop FF provides a storage for the output signal for one clock pulse in order to allow the signal to settle down and to provide a buffer between the output of the delta modulator and the modulator itself.
The foregoing description is intended by way of example only and is not intended to limit the present invention in any way except as set forth in the following claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4453551 *||Feb 25, 1981||Jun 12, 1984||John Anderson||Apparatus for pattern recognition of ECG signals for detecting fibrillation|
|US4552154 *||Mar 12, 1984||Nov 12, 1985||Medtronic, Inc.||Waveform morphology discriminator and method|
|US4679144 *||Aug 21, 1984||Jul 7, 1987||Q-Med, Inc.||Cardiac signal real time monitor and method of analysis|
|US4925443 *||Feb 27, 1987||May 15, 1990||Heilman Marlin S||Biocompatible ventricular assist and arrhythmia control device|
|US5014284 *||Jun 30, 1989||May 7, 1991||Cardiac Telecom Corporation||Discrete slope delta modulation with recovery means|
|US5058599 *||Jun 14, 1990||Oct 22, 1991||Siemens Aktiengesellschaft||Method and apparatus for detecting a sequence of abnormal events in an electrical signal, particularly in the depolarization signal of a heart|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US5560369 *||Sep 22, 1994||Oct 1, 1996||Pacesetter, Inc.||Cardiac arrhythmia detection system for an implantable stimulation device and method|
|US5836889 *||Mar 3, 1997||Nov 17, 1998||Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin||Method and apparatus for storing signals in an implantable medical device|
|US6061592 *||May 6, 1998||May 9, 2000||Biotronik Mess-Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin||Device for detecting tachycardia using a counter|
|US6112117 *||May 6, 1997||Aug 29, 2000||Cardiac Pacemakers, Inc.||Method and apparatus for treating cardiac arrhythmia using electrogram features|
|US6251125||Apr 1, 1998||Jun 26, 2001||Cardiac Pacemakers, Inc.||Method and apparatus for treating ventricular fibrillation using electrogram features|
|US6539256||Jul 6, 2000||Mar 25, 2003||Cardiac Pacemakers, Inc.||Method and apparatus for treating cardiac arrhythmia using electrogram features|
|US6823209||Oct 19, 2001||Nov 23, 2004||Medtronic Physio-Control Corp.||Electrocardiogram filter|
|US6839591||Mar 24, 2003||Jan 4, 2005||Cardiac Pacemakers, Inc.||Method and apparatus for treating cardiac arrhythmia using electrogram features|
|US7047071||Mar 12, 2004||May 16, 2006||Cardiac Pacemakers, Inc.||Patient stratification for implantable subcutaneous cardiac monitoring and therapy|
|US7117035||Apr 1, 2004||Oct 3, 2006||Cardiac Pacemakers, Inc.||Subcutaneous cardiac stimulation system with patient activity sensing|
|US7162299 *||Jun 5, 2002||Jan 9, 2007||Pacesetter, Inc.||ICD with VF prevention|
|US7218966||Mar 19, 2004||May 15, 2007||Cardiac Pacemakers, Inc.||Multi-parameter arrhythmia discrimination|
|US7236819||Dec 19, 2003||Jun 26, 2007||Cardiac Pacemakers, Inc.||Separation of a subcutaneous cardiac signal from a plurality of composite signals|
|US7302294||Apr 2, 2004||Nov 27, 2007||Cardiac Pacemakers, Inc.||Subcutaneous cardiac sensing and stimulation system employing blood sensor|
|US7349742||Dec 23, 2003||Mar 25, 2008||Cardiac Pacemakers, Inc.||Expandable fixation elements for subcutaneous electrodes|
|US7369890||May 9, 2003||May 6, 2008||Cardiac Pacemakers, Inc.||Technique for discriminating between coordinated and uncoordinated cardiac rhythms|
|US7389138||Mar 19, 2004||Jun 17, 2008||Cardiac Pacemakers, Inc.||Electrode placement determination for subcutaneous cardiac monitoring and therapy|
|US7392081||Feb 28, 2003||Jun 24, 2008||Cardiac Pacemakers, Inc.||Subcutaneous cardiac stimulator employing post-shock transthoracic asystole prevention pacing|
|US7392086||Apr 26, 2005||Jun 24, 2008||Cardiac Pacemakers, Inc.||Implantable cardiac device and method for reduced phrenic nerve stimulation|
|US7425210||Dec 22, 2003||Sep 16, 2008||Cardiac Pacemakers, Inc.||Drug delivery system for implantable medical device|
|US7457664||May 9, 2005||Nov 25, 2008||Cardiac Pacemakers, Inc.||Closed loop cardiac resynchronization therapy using cardiac activation sequence information|
|US7468040||Aug 30, 2004||Dec 23, 2008||Cardiac Pacemakers, Inc.||Methods and systems for implantably monitoring external breathing therapy|
|US7469697||Jun 9, 2004||Dec 30, 2008||Cardiac Pacemakers, Inc.||Feedback system and method for sleep disordered breathing therapy|
|US7493175||Dec 18, 2003||Feb 17, 2009||Cardiac Pacemakers, Inc.||Subcutaneous lead with tined fixation|
|US7499750||Dec 17, 2003||Mar 3, 2009||Cardiac Pacemakers, Inc.||Noise canceling cardiac electrodes|
|US7499758||Dec 18, 2003||Mar 3, 2009||Cardiac Pacemakers, Inc.||Helical fixation elements for subcutaneous electrodes|
|US7509170||May 9, 2005||Mar 24, 2009||Cardiac Pacemakers, Inc.||Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes|
|US7510531||Apr 15, 2004||Mar 31, 2009||Cardiac Pacemakers, Inc.||System and method for discrimination of central and obstructive disordered breathing events|
|US7529592||Nov 7, 2003||May 5, 2009||Cardiac Pacemakers, Inc.||Subcutaneous electrode and lead with temporary pharmacological agents|
|US7555335||Apr 8, 2004||Jun 30, 2009||Cardiac Pacemakers, Inc.||Biopotential signal source separation using source impedances|
|US7566318||Sep 2, 2003||Jul 28, 2009||Cardiac Pacemakers, Inc.||Ultrasonic subcutaneous dissection tool incorporating fluid delivery|
|US7570997||Apr 8, 2004||Aug 4, 2009||Cardiac Pacemakers, Inc.||Subcutaneous cardiac rhythm management with asystole prevention therapy|
|US7572225||Aug 17, 2004||Aug 11, 2009||Cardiac Pacemakers, Inc.||Sleep logbook|
|US7575553||Aug 31, 2004||Aug 18, 2009||Cardiac Pacemakers, Inc.||Methods and systems for assessing pulmonary disease|
|US7591265||Aug 31, 2004||Sep 22, 2009||Cardiac Pacemakers, Inc.||Coordinated use of respiratory and cardiac therapies for sleep disordered breathing|
|US7610094||Sep 13, 2004||Oct 27, 2009||Cardiac Pacemakers, Inc.||Synergistic use of medical devices for detecting medical disorders|
|US7623913||Aug 1, 2006||Nov 24, 2009||Cameron Health, Inc.||Implantable medical devices using heuristic filtering in cardiac event detection|
|US7627373||Nov 25, 2003||Dec 1, 2009||Cardiac Pacemakers, Inc.||Method and apparatus for cell and electrical therapy of living tissue|
|US7647108||Sep 30, 2004||Jan 12, 2010||Cardiac Pacemakers, Inc.||Methods and systems for selection of cardiac pacing electrode configurations|
|US7668591||Aug 20, 2004||Feb 23, 2010||Cardiac Pacemakers, Inc.||Automatic activation of medical processes|
|US7678061||Apr 15, 2004||Mar 16, 2010||Cardiac Pacemakers, Inc.||System and method for characterizing patient respiration|
|US7680534||Mar 16, 2010||Cardiac Pacemakers, Inc.||Implantable cardiac device with dyspnea measurement|
|US7702399||Dec 4, 2003||Apr 20, 2010||Cardiac Pacemakers, Inc.||Subcutaneous electrode and lead with phoresis based pharmacological agent delivery|
|US7706866||Jun 24, 2004||Apr 27, 2010||Cardiac Pacemakers, Inc.||Automatic orientation determination for ECG measurements using multiple electrodes|
|US7715916||May 15, 2007||May 11, 2010||Cardiac Pacemakers, Inc.||Multi-parameter arrhythmia discrimination|
|US7757690||Sep 13, 2004||Jul 20, 2010||Cardiac Pacemakers, Inc.||System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep|
|US7761158||Dec 20, 2005||Jul 20, 2010||Cardiac Pacemakers, Inc.||Detection of heart failure decompensation based on cumulative changes in sensor signals|
|US7766840||Dec 1, 2005||Aug 3, 2010||Cardiac Pacemakers, Inc.||Method and system for heart failure status evaluation based on a disordered breathing index|
|US7774064||Dec 12, 2003||Aug 10, 2010||Cardiac Pacemakers, Inc.||Cardiac response classification using retriggerable classification windows|
|US7774934||Dec 8, 2005||Aug 17, 2010||Cardiac Pacemakers, Inc.||Method for making a terminal connector|
|US7775983||Sep 16, 2005||Aug 17, 2010||Cardiac Pacemakers, Inc.||Rapid shallow breathing detection for use in congestive heart failure status determination|
|US7787946||Sep 17, 2004||Aug 31, 2010||Cardiac Pacemakers, Inc.||Patient monitoring, diagnosis, and/or therapy systems and methods|
|US7797036||Mar 14, 2005||Sep 14, 2010||Cardiac Pacemakers, Inc.||Cardiac activation sequence monitoring for ischemia detection|
|US7805185||May 9, 2005||Sep 28, 2010||Cardiac Pacemakers, In.||Posture monitoring using cardiac activation sequences|
|US7819816||Mar 29, 2006||Oct 26, 2010||Cardiac Pacemakers, Inc.||Periodic disordered breathing detection|
|US7865233||Feb 23, 2004||Jan 4, 2011||Cardiac Pacemakers, Inc.||Subcutaneous cardiac signal discrimination employing non-electrophysiologic signal|
|US7887493||Sep 13, 2004||Feb 15, 2011||Cardiac Pacemakers, Inc.||Implantable device employing movement sensing for detecting sleep-related disorders|
|US7890159||Sep 30, 2004||Feb 15, 2011||Cardiac Pacemakers, Inc.||Cardiac activation sequence monitoring and tracking|
|US7917196||May 9, 2005||Mar 29, 2011||Cardiac Pacemakers, Inc.||Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes|
|US7917215||Nov 21, 2008||Mar 29, 2011||Cardiac Pacemakers, Inc.||Closed loop cardiac resynchronization therapy using cardiac activation sequence information|
|US7938782||May 12, 2008||May 10, 2011||Cardiac Pacemakers, Inc.||Prediction of disordered breathing|
|US7941206||Jan 27, 2010||May 10, 2011||Cardiac Pacemakers, Inc.||Automatic orientation determination for ECG measurements using multiple electrodes|
|US7941208||Mar 7, 2007||May 10, 2011||Cardiac Pacemakers, Inc.||Therapy delivery for identified tachyarrhythmia episode types|
|US7967756||Sep 15, 2004||Jun 28, 2011||Cardiac Pacemakers, Inc.||Respiratory therapy control based on cardiac cycle|
|US7974685||May 22, 2007||Jul 5, 2011||Cardiac Pacemakers, Inc.||Systems, devices, and methods for tachyarrhythmia discrimination or therapy decisions|
|US7979122||Apr 8, 2004||Jul 12, 2011||Cardiac Pacemakers, Inc.||Implantable sudden cardiac death prevention device with reduced programmable feature set|
|US7981065||Dec 20, 2004||Jul 19, 2011||Cardiac Pacemakers, Inc.||Lead electrode incorporating extracellular matrix|
|US7993279||Jul 15, 2008||Aug 9, 2011||Cardiac Pacemakers, Inc.||Methods and systems for implantably monitoring external breathing therapy|
|US7996071||Jun 30, 2009||Aug 9, 2011||Cardiac Pacemakers, Inc.||Biopotential signal source separation using source impedances|
|US7996072||Dec 21, 2004||Aug 9, 2011||Cardiac Pacemakers, Inc.||Positionally adaptable implantable cardiac device|
|US7996082 *||Aug 9, 2011||Cameron Health, Inc.||Method and devices for performing cardiac waveform appraisal|
|US8024039||Oct 17, 2007||Sep 20, 2011||Cardiac Pacemakers, Inc.||Subcutaneous cardiac sensing and stimulation system employing blood sensor|
|US8060219||Dec 20, 2004||Nov 15, 2011||Cardiac Pacemakers, Inc.||Epicardial patch including isolated extracellular matrix with pacing electrodes|
|US8104470||Aug 21, 2009||Jan 31, 2012||Cardiac Pacemakers, Inc.||Coordinated use of respiratory and cardiac therapies for sleep disordered breathing|
|US8116841||Sep 12, 2008||Feb 14, 2012||Corventis, Inc.||Adherent device with multiple physiological sensors|
|US8116868||Mar 15, 2004||Feb 14, 2012||Cardiac Pacemakers, Inc.||Implantable device with cardiac event audio playback|
|US8116871||Mar 23, 2009||Feb 14, 2012||Cardiac Pacemakers, Inc.||Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes|
|US8145310||Jul 7, 2008||Mar 27, 2012||Cardiac Pacemakers, Inc.||Non-captured intrinsic discrimination in cardiac pacing response classification|
|US8185202||May 22, 2008||May 22, 2012||Cardiac Pacemakers, Inc.||Implantable cardiac device for reduced phrenic nerve stimulation|
|US8209013||Sep 14, 2006||Jun 26, 2012||Cardiac Pacemakers, Inc.||Therapeutic electrical stimulation that avoids undesirable activation|
|US8209035||Jun 23, 2008||Jun 26, 2012||Cardiac Pacemakers, Inc.||Extendable and retractable lead having a snap-fit terminal connector|
|US8221327||Jan 15, 2010||Jul 17, 2012||Cardiac Pacemakers, Inc.||Therapy control based on cardiopulmonary status|
|US8249686||Sep 12, 2008||Aug 21, 2012||Corventis, Inc.||Adherent device for sleep disordered breathing|
|US8251061||Aug 30, 2004||Aug 28, 2012||Cardiac Pacemakers, Inc.||Methods and systems for control of gas therapy|
|US8255052||Mar 25, 2009||Aug 28, 2012||Cardiac Pacemakers, Inc.||Temperature based systems and methods for tachycardia discrimination and therapy|
|US8260421||May 22, 2008||Sep 4, 2012||Cardiac Pacemakers, Inc.||Method for reducing phrenic nerve stimulation|
|US8265736||Aug 7, 2007||Sep 11, 2012||Cardiac Pacemakers, Inc.||Method and apparatus to perform electrode combination selection|
|US8285356||Jan 10, 2012||Oct 9, 2012||Corventis, Inc.||Adherent device with multiple physiological sensors|
|US8285398||Jul 7, 2010||Oct 9, 2012||Cardiac Pacemakers, Inc.||Lead with terminal connector assembly|
|US8321022||Mar 24, 2010||Nov 27, 2012||Cardiac Pacemakers, Inc.||Adaptive therapy for disordered breathing|
|US8323204||Mar 13, 2009||Dec 4, 2012||Cardiac Pacemakers, Inc.||Medical event logbook system and method|
|US8346357 *||May 21, 2012||Jan 1, 2013||Cameron Health, Inc.||Method and devices for performing cardiac waveform appraisal|
|US8374688||Sep 12, 2008||Feb 12, 2013||Corventis, Inc.||System and methods for wireless body fluid monitoring|
|US8380296||Feb 19, 2013||Cardiac Pacemakers, Inc.||Automatic activation of medical processes|
|US8412317||Apr 20, 2009||Apr 2, 2013||Corventis, Inc.||Method and apparatus to measure bioelectric impedance of patient tissue|
|US8412325||Apr 6, 2009||Apr 2, 2013||Cardiac Pacemakers, Inc.||High-energy anti-tachycardia therapy|
|US8460189||Sep 12, 2008||Jun 11, 2013||Corventis, Inc.||Adherent cardiac monitor with advanced sensing capabilities|
|US8496596||Feb 5, 2010||Jul 30, 2013||Cardiac Pacemakers, Inc.||Systems and methods for determining respiration metrics|
|US8515535||Jan 28, 2010||Aug 20, 2013||Cardiac Pacemakers, Inc.||Implantable cardiac device with dyspnea measurement|
|US8521284||Dec 12, 2003||Aug 27, 2013||Cardiac Pacemakers, Inc.||Cardiac response classification using multisite sensing and pacing|
|US8522779||Jan 31, 2012||Sep 3, 2013||Cardiac Pacemakers, Inc.||Coordinated use of respiratory and cardiac therapies for sleep disordered breathing|
|US8527048||Jun 29, 2006||Sep 3, 2013||Cardiac Pacemakers, Inc.||Local and non-local sensing for cardiac pacing|
|US8591430||Sep 12, 2008||Nov 26, 2013||Corventis, Inc.||Adherent device for respiratory monitoring|
|US8600502||Jun 5, 2012||Dec 3, 2013||Cardiac Pacemakers, Inc.||Sleep state classification|
|US8606356||Aug 17, 2004||Dec 10, 2013||Cardiac Pacemakers, Inc.||Autonomic arousal detection system and method|
|US8606357||Dec 22, 2008||Dec 10, 2013||Cardiac Pacemakers, Inc.||Cardiac waveform template creation, maintenance and use|
|US8615297||Aug 27, 2012||Dec 24, 2013||Cardiac Pacemakers, Inc.||Method and apparatus to perform electrode combination selection|
|US8626276||Jul 30, 2010||Jan 7, 2014||Cardiac Pacemakers, Inc.||Cardiac activation sequence monitoring for ischemia detection|
|US8626285||Dec 27, 2012||Jan 7, 2014||Cameron Health, Inc.||Method and devices for performing cardiac waveform appraisal|
|US8649866||Feb 10, 2009||Feb 11, 2014||Cardiac Pacemakers, Inc.||Method and apparatus for phrenic stimulation detection|
|US8684925||Sep 12, 2008||Apr 1, 2014||Corventis, Inc.||Injectable device for physiological monitoring|
|US8700138||Aug 21, 2009||Apr 15, 2014||Cardiac Pacemakers, Inc.||Methods and devices for determination of arrhythmia rate zone thresholds|
|US8712507||Dec 21, 2006||Apr 29, 2014||Cardiac Pacemakers, Inc.||Systems and methods for arranging and labeling cardiac episodes|
|US8718752||Mar 11, 2009||May 6, 2014||Corventis, Inc.||Heart failure decompensation prediction based on cardiac rhythm|
|US8750992||Aug 15, 2013||Jun 10, 2014||Cardiac Pacemakers, Inc.||Implantable cardiac device with dyspnea measurement|
|US8790257||Sep 12, 2008||Jul 29, 2014||Corventis, Inc.||Multi-sensor patient monitor to detect impending cardiac decompensation|
|US8790259||Oct 22, 2010||Jul 29, 2014||Corventis, Inc.||Method and apparatus for remote detection and monitoring of functional chronotropic incompetence|
|US8825148||Nov 7, 2012||Sep 2, 2014||Siemens Medical Solutions Usa, Inc.||System for monitoring and diagnosis of cardiac electrogram signals using multi-dimensional analysis|
|US8831726||Jan 15, 2008||Sep 9, 2014||Cardiac Pacemakers, Inc.||Cardiac response classification using multiple classification windows|
|US8843196||Sep 20, 2011||Sep 23, 2014||Cardiac Pacemakers, Inc.||Subcutaneous cardiac sensing and stimulation system|
|US8843199||Aug 26, 2013||Sep 23, 2014||Cardiac Pacemakers, Inc.||Cardiac response classification using multisite sensing and pacing|
|US8897868||Sep 12, 2008||Nov 25, 2014||Medtronic, Inc.||Medical device automatic start-up upon contact to patient tissue|
|US8948867||Sep 14, 2006||Feb 3, 2015||Cardiac Pacemakers, Inc.||Capture detection with cross chamber backup pacing|
|US8954146||Apr 16, 2014||Feb 10, 2015||Cardiac Pacemakers, Inc.||Implantable cardiac device with dyspnea measurement|
|US8965498||Mar 28, 2011||Feb 24, 2015||Corventis, Inc.||Method and apparatus for personalized physiologic parameters|
|US8983602||Nov 20, 2013||Mar 17, 2015||Cardiac Pacemakers, Inc.||Method and apparatus to perform electrode combination selection|
|US8996112||Jan 17, 2014||Mar 31, 2015||Cardiac Pacemakers, Inc.||Method and apparatus for phrenic stimulation detection|
|US8998821||Jul 26, 2013||Apr 7, 2015||Cardiac Pacemakers, Inc.||Systems and methods for determining respiration metrics|
|US9002467||Oct 9, 2014||Apr 7, 2015||Cardiac Pacemakers, Inc.||Modular antitachyarrhythmia therapy system|
|US9008771||Mar 5, 2012||Apr 14, 2015||Cardiac Pacemakers, Inc.||Non-captured intrinsic discrimination in cardiac pacing response classification|
|US9008775||Mar 13, 2014||Apr 14, 2015||Cardiac Pacemakers, Inc.||Method and apparatus to perform electrode combination selection|
|US9014819||Nov 12, 2013||Apr 21, 2015||Cardiac Pacemakers, Inc.||Autonomic arousal detection system and method|
|US9037239||Jul 24, 2008||May 19, 2015||Cardiac Pacemakers, Inc.||Method and apparatus to perform electrode combination selection|
|US9079033||Jan 20, 2009||Jul 14, 2015||Cardiac Pacemakers, Inc.||Respiration as a trigger for therapy optimization|
|US9095265||Nov 20, 2013||Aug 4, 2015||Cardiac Pacemakers, Inc.||Cardiac waveform template creation, maintenance and use|
|US9119547 *||Jan 12, 2010||Sep 1, 2015||Cardiac Pacemakers, Inc.||Arrhythmia discrimination based on determination of rate dependency|
|US9138151||Jan 28, 2014||Sep 22, 2015||Cardiac Pacemakers, Inc.||Method and apparatus for management of heart failure hospitalization|
|US9173615||Sep 23, 2014||Nov 3, 2015||Medtronic Monitoring, Inc.||Method and apparatus for personalized physiologic parameters|
|US9186089||Sep 12, 2008||Nov 17, 2015||Medtronic Monitoring, Inc.||Injectable physiological monitoring system|
|US9242113||Mar 5, 2015||Jan 26, 2016||Cardiac Pacemarkers, Inc.||Modular antitachyarrhythmia therapy system|
|US20040073262 *||May 9, 2003||Apr 15, 2004||Cardiac Pacemakers, Inc.||Technique for discriminating between coordinated and uncoordinated cardiac rhythms|
|US20040138648 *||Dec 22, 2003||Jul 15, 2004||Cardiac Pacemakers, Inc.||Drug delivery system for implantable medical device|
|US20040172066 *||Feb 28, 2003||Sep 2, 2004||Wagner Darrell Orvin||Subcutaneous cardiac stimulator employing post-shock transthoracic asystole prevention pacing|
|US20040204728 *||Sep 2, 2003||Oct 14, 2004||Paul Haefner||Ultrasonic subcutaneous dissection tool incorporating fluid delivery|
|US20040204734 *||Jul 23, 2003||Oct 14, 2004||Wagner Darrell Orvin||Tunneling tool with subcutaneous transdermal illumination|
|US20040204735 *||Jul 23, 2003||Oct 14, 2004||Shiroff Jason Alan||Subcutaneous dissection tool incorporating pharmacological agent delivery|
|US20040215239 *||Apr 8, 2004||Oct 28, 2004||Mike Favet||Implantable sudden cardiac death prevention device with reduced programmable feature set|
|US20040215240 *||Apr 8, 2004||Oct 28, 2004||Lovett Eric G.||Reconfigurable subcutaneous cardiac device|
|US20040220626 *||Apr 7, 2004||Nov 4, 2004||Wagner Darrell Orvin||Distributed subcutaneous defibrillation system|
|US20040220628 *||Apr 5, 2004||Nov 4, 2004||Wagner Darrell Orvin||Subcutaneous defibrillation timing correlated with induced skeletal muscle contraction|
|US20040220629 *||Apr 2, 2004||Nov 4, 2004||Apurv Kamath||Subcutaneous cardiac sensing and stimulation system employing blood sensor|
|US20040225329 *||Mar 19, 2004||Nov 11, 2004||Wagner Darrell Orvin||Electrode placement determination for subcutaneous cardiac monitoring and therapy|
|US20040230129 *||Mar 19, 2004||Nov 18, 2004||Paul Haefner||Multi-parameter arrhythmia discrimination|
|US20040230243 *||Dec 17, 2003||Nov 18, 2004||Paul Haefner||Noise canceling cardiac electrodes|
|US20040230272 *||Nov 7, 2003||Nov 18, 2004||Cates Adam W.||Subcutaneous lead with temporary pharmacological agents|
|US20040230274 *||Dec 4, 2003||Nov 18, 2004||Ron Heil||Subcutaneous electrode and lead with phoresis based pharmacological agent delivery|
|US20040230280 *||Dec 18, 2003||Nov 18, 2004||Cates Adam W.||Helical fixation elements for subcutaneous electrodes|
|US20040230281 *||Dec 23, 2003||Nov 18, 2004||Ron Heil||Expandable fixation elements for subcutaneous electrodes|
|US20050004615 *||Feb 24, 2004||Jan 6, 2005||Sanders Richard S.||Reconfigurable implantable cardiac monitoring and therapy delivery device|
|US20050061315 *||Jun 9, 2004||Mar 24, 2005||Kent Lee||Feedback system and method for sleep disordered breathing therapy|
|US20050061319 *||Aug 30, 2004||Mar 24, 2005||Cardiac Pacemakers, Inc.||Methods and systems for implantably monitoring external breathing therapy|
|US20050061320 *||Aug 31, 2004||Mar 24, 2005||Cardiac Pacemakers, Inc.||Coordinated use of respiratory and cardiac therapies for sleep disordered breathing|
|US20050061323 *||Aug 30, 2004||Mar 24, 2005||Cardiac Pacemakers, Inc.||Methods and systems for control of gas therapy|
|US20050065447 *||Apr 15, 2004||Mar 24, 2005||Kent Lee||System and method for characterizing patient respiration|
|US20050065448 *||Aug 31, 2004||Mar 24, 2005||Cardiac Pacemakers, Inc.||Methods and systems for assessing pulmonary disease|
|US20050074741 *||Apr 15, 2004||Apr 7, 2005||Kent Lee||System and method for discrimination of central and obstructive disordered breathing events|
|US20050076908 *||Aug 17, 2004||Apr 14, 2005||Kent Lee||Autonomic arousal detection system and method|
|US20050076909 *||Sep 13, 2004||Apr 14, 2005||Stahmann Jeffrey E.||Synergistic use of medical devices for detecting medical disorders|
|US20050080348 *||Aug 17, 2004||Apr 14, 2005||Stahmann Jeffrey E.||Medical event logbook system and method|
|US20050085738 *||Aug 17, 2004||Apr 21, 2005||Stahmann Jeffrey E.||Sleep logbook|
|US20050107838 *||Aug 17, 2004||May 19, 2005||Lovett Eric G.||Subcutaneous cardiac rhythm management with disordered breathing detection and treatment|
|US20050109339 *||Sep 15, 2004||May 26, 2005||Stahmann Jeffrey E.||Respiratory therapy control based on cardiac cycle|
|US20050131477 *||Dec 12, 2003||Jun 16, 2005||Meyer Scott A.||Cardiac response classification using retriggerable classification windows|
|US20050131478 *||Dec 12, 2003||Jun 16, 2005||Jaeho Kim||Cardiac response classification using multisite sensing and pacing|
|US20050142070 *||Sep 15, 2004||Jun 30, 2005||Hartley Jesse W.||Methods and systems for assessing pulmonary disease with drug therapy control|
|US20050215884 *||Feb 25, 2005||Sep 29, 2005||Greicius Michael D||Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI|
|US20050288600 *||Jun 24, 2004||Dec 29, 2005||Yi Zhang||Automatic orientation determination for ECG measurements using multiple electrodes|
|US20060069322 *||Sep 30, 2004||Mar 30, 2006||Yi Zhang||Cardiac activation sequence monitoring and tracking|
|US20060074454 *||Sep 30, 2004||Apr 6, 2006||Freeberg Scott M||Methods and systems for selection of cardiac pacing electrode configurations|
|US20060116593 *||Mar 14, 2005||Jun 1, 2006||Yi Zhang||Cardiac activation sequence monitoring for ischemia detection|
|US20060143138 *||Mar 29, 2005||Jun 29, 2006||Fujitsu Limited||Password input method|
|US20060167502 *||Dec 21, 2004||Jul 27, 2006||Haefner Paul A||Positionally adaptable implantable cardiac device|
|US20060195149 *||Feb 28, 2005||Aug 31, 2006||Hopper Donald L||Implantable cardiac device with dyspnea measurement|
|US20060241711 *||Apr 26, 2005||Oct 26, 2006||Sathaye Alok S||Implantable cardiac device and method for reduced phrenic nerve stimulation|
|US20060253043 *||May 9, 2005||Nov 9, 2006||Yi Zhang||Posture monitoring using cardiac activation sequences|
|US20060253044 *||May 9, 2005||Nov 9, 2006||Yi Zhang||Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes|
|US20060253162 *||May 9, 2005||Nov 9, 2006||Yi Zhang||Closed loop cardiac resynchronization therapy using cardiac activation sequence information|
|US20060253164 *||May 9, 2005||Nov 9, 2006||Yi Zhang||Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes|
|US20070049975 *||Sep 1, 2005||Mar 1, 2007||Cates Adam W||Active can with dedicated defibrillation and sensing electrodes|
|US20070055115 *||Sep 8, 2005||Mar 8, 2007||Jonathan Kwok||Characterization of sleep disorders using composite patient data|
|US20070073168 *||Sep 16, 2005||Mar 29, 2007||Yi Zhang||Rapid shallow breathing detection for use in congestive heart failure status determination|
|US20070118180 *||Nov 18, 2005||May 24, 2007||Quan Ni||Cardiac resynchronization therapy for improved hemodynamics based on disordered breathing detection|
|US20070135847 *||Dec 12, 2005||Jun 14, 2007||Kenknight Bruce H||Subcutaneous defibrillation system and method using same|
|US20070142732 *||Dec 20, 2005||Jun 21, 2007||Marina Brockway||Detection of heart failure decompensation based on cumulative changes in sensor signals|
|US20070219456 *||May 22, 2007||Sep 20, 2007||Cardiac Pacemakers, Inc||Systems, devices, and methods for tachyarrhythmia discrimination or therapy decisions|
|US20070239057 *||Mar 29, 2006||Oct 11, 2007||Yanchuan Pu||Periodic disordered breathing detection|
|US20070260151 *||Sep 6, 2006||Nov 8, 2007||Clifford Gari D||Method and device for filtering, segmenting, compressing and classifying oscillatory signals|
|US20070293896 *||May 15, 2007||Dec 20, 2007||Paul Haefner||Multi-parameter arrhythmia discrimination|
|US20080004665 *||Jun 29, 2006||Jan 3, 2008||Mccabe Aaron R||Determination of cardiac pacing parameters based on non-localized sensing|
|US20080009909 *||Jun 29, 2006||Jan 10, 2008||Sathaye Alok S||Local and non-local sensing for cardiac pacing|
|US20080015647 *||Jul 23, 2007||Jan 17, 2008||Cameron Health, Inc.||Method and devices for performing cardiac waveform appraisal|
|US20080045850 *||Aug 1, 2006||Feb 21, 2008||Cameron Health, Inc.||Implantable medical devices using heuristic filtering in cardiac event detection|
|US20080071182 *||Dec 21, 2006||Mar 20, 2008||Shelley Cazares||Systems and methods for arranging and labeling cardiac episodes|
|US20080091242 *||Oct 17, 2007||Apr 17, 2008||Apurv Kamath||Subcutaneous cardiac sensing and stimulation system employing blood sensor|
|US20080125824 *||Mar 7, 2007||May 29, 2008||Sauer William H||Therapy delivery for identified tachyarrhythmia episode types|
|US20080154324 *||Jan 15, 2008||Jun 26, 2008||Cardiac Pacemakers, Inc.||Cardiac response classification using multiple classification windows|
|US20080221468 *||May 12, 2008||Sep 11, 2008||Stahmann Jeffrey E||Prediction of disordered breathing|
|US20080228093 *||Mar 13, 2007||Sep 18, 2008||Yanting Dong||Systems and methods for enhancing cardiac signal features used in morphology discrimination|
|US20080312548 *||Jul 15, 2008||Dec 18, 2008||Hartley Jesse W||Methods and systems for implantably monitoring external breathing therapy|
|US20090043351 *||Aug 7, 2007||Feb 12, 2009||Sathaye Alok S||Method and apparatus to perform electrode combination selection|
|US20090105778 *||Dec 22, 2008||Apr 23, 2009||Kent Lee||Cardiac Waveform Template Creation, Maintenance and Use|
|US20090163973 *||Mar 2, 2009||Jun 25, 2009||Meyer Scott A||Cardiac Signal Template Generation Using Waveform Clustering|
|US20090177702 *||Mar 13, 2009||Jul 9, 2009||Stahmann Jeffrey E||Medical Event Logbook System and Method|
|US20090198301 *||Mar 23, 2009||Aug 6, 2009||Yi Zhang||Automatic Capture Verification using Electrocardiograms Sensed from Multiple Implanted Electrodes|
|US20090210024 *||Feb 10, 2009||Aug 20, 2009||M Brooke Jason||Method and Apparatus for Phrenic Stimulation Detection|
|US20090234240 *||Jan 20, 2009||Sep 17, 2009||Kuenzler Richard O||Respiration as a Trigger for Therapy Optimization|
|US20090254135 *||Apr 6, 2009||Oct 8, 2009||Cardiac Pacemakers, Inc.||High-energy anti-tachycardia therapy|
|US20090254137 *||Mar 25, 2009||Oct 8, 2009||Cardiac Pacemakers, Inc.||Temperature Based Systems and Methods for Tachycardia Discrimination and Therapy|
|US20090270750 *||Jun 30, 2009||Oct 29, 2009||Apurv Kamath||Biopotential Signal Source Separation Using Source Impedances|
|US20090287070 *||Nov 19, 2009||Nellcor Puritan Bennett Llc||Estimation Of A Physiological Parameter Using A Neural Network|
|US20090312813 *||Aug 21, 2009||Dec 17, 2009||Shelley Marie Cazares||Method and Device for Determination of Arrhythmia Rate Zone Thresholds|
|US20100106211 *||Dec 30, 2009||Apr 29, 2010||Kent Lee||Automatic Activation of Medical Processes|
|US20100121209 *||Jan 12, 2010||May 13, 2010||Shelley Cazares||Arrhythmia Discrimination Based on Determination of Rate Dependency|
|US20100137730 *||Feb 5, 2010||Jun 3, 2010||John Hatlestad||Systems and Methods for Determining Respiration Metrics|
|US20100137931 *||Jan 28, 2010||Jun 3, 2010||Hopper Donald L||Implantable Cardiac Device With Dyspnea Measurement|
|US20100174154 *||Jul 8, 2010||Kent Lee||Therapy Control Based on Cardiopulmonary Status|
|US20100174207 *||Mar 15, 2010||Jul 8, 2010||Kent Lee||System and Method for Characterizing Patient Respiration|
|US20100174335 *||Mar 16, 2010||Jul 8, 2010||Stahmann Jeffrey E||Therapy Triggered by Predication of Disordered Breathing|
|US20100179613 *||Mar 24, 2010||Jul 15, 2010||Stahmann Jeffrey E||Adaptive Therapy for Disordered Breathing|
|US20100198283 *||Aug 5, 2010||Yi Zhang||Automatic Orientation Determination for ECG Measurements Using Multiple Electrodes|
|US20100298729 *||Jul 30, 2010||Nov 25, 2010||Yi Zhang||Cardiac Activation Sequence Monitoring for Ischemia Detection|
|US20110009760 *||May 26, 2010||Jan 13, 2011||Yi Zhang||Hospital Readmission Alert for Heart Failure Patients|
|US20120232415 *||Sep 13, 2012||Cameron Health, Inc.||Method and Devices for Performing Cardiac Waveform Appraisal|
|USRE38712 *||Nov 15, 2002||Mar 22, 2005||Biotronik Mess- Und Therapiegeraete Gmbh & Co.||Method and apparatus for storing signals in an implantable medical device|
|U.S. Classification||600/518, 600/515|
|International Classification||A61B5/0468, A61B5/0464, G06F17/00, A61B5/046, A61N1/37, A61B5/0452, A61B5/044|
|Cooperative Classification||A61B5/0468, A61N1/3702, A61B5/046, A61B5/0464|
|European Classification||A61B5/046, A61N1/37B, A61B5/0468, A61B5/0464|
|Mar 9, 1992||AS||Assignment|
Owner name: CARDIAC PACEMAKERS, INC. A CORP. OF MINNESOTA, M
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:HSUNG, JEAN-CHEUI;REEL/FRAME:006034/0917
Effective date: 19920129
|Mar 17, 1998||FPAY||Fee payment|
Year of fee payment: 4
|Mar 17, 1998||SULP||Surcharge for late payment|
|Nov 6, 2001||REMI||Maintenance fee reminder mailed|
|Nov 7, 2001||FPAY||Fee payment|
Year of fee payment: 8
|Nov 7, 2001||SULP||Surcharge for late payment|
Year of fee payment: 7
|Oct 3, 2005||FPAY||Fee payment|
Year of fee payment: 12